Main Article Content
Abstract
Artabotrys hexapetalus, a climbing shrub native to India and Southeast Asia, has gained attention in traditional medicine for its diverse therapeutic applications. This research examines the ethnobotanical uses, and pharmacological properties of A. hexapetalus, emphasizing its potential as a valuable medicinal plant. This paper aims to consolidate current knowledge, fostering future research into the pharmacological potential of A. hexapetalus. Research on plant part flowers has identified the presence of alkaloids, flavonoids, tannins, phenolics, and terpenoids. It reveals a diverse array of bioactive compounds, supporting its traditional medicinal uses. It reflects a greater reduction in the DPPH radical. % inhibition of Artabotrys hexapetalus 48.9 ± 1.5. A lower absorbance reading indicates a higher free radical scavenging activity of the extract. Inhibitors of alpha-glucosidase can slow down the absorption of glucose from the intestines, thereby helping in the management of postprandial hyperglycemia, a common feature of type 2 diabetes mellitus. In this study, the alpha-glucosidase inhibitory activity of Artabotrys hexapetalus flowers was tested at different concentrations and the results were compared to the standard drug acarbose. The growing cells were made in to scratch wounds after the treating with ethanolic extract was noted with MRI image analysis software. The time intervals show the result as 0 hour at 2386659, 24 hours at 1174269, 48 hours at 679741, 72 hours at 324498 wound area (px). The ethanolic extract was given notable results. Despite its wide usage, there is limited published data synthesizing its medicinal properties. This research aims to provide a detailed examination of A. hexapetalus, drawing attention to its potential for pharmacological applications